Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Rep. Barton questions FDA's use of "social policy" in home-use diagnostics review.

This article was originally published in The Tan Sheet

Executive Summary

REP. BARTON QUESTIONS FDA HOME-USE DIAGNOSTIC TEST REVIEW in a May 8 letter to FDA Commissioner David Kessler, MD. House Com-merce/Over-sight Subcommittee Chairman Joe Barton (R-Tex.) asked Kessler, "What is FDA's social policy position (as opposed to safety and efficacy) on home drug testing?" Barton requested that the agency respond to the letter by May 22.

Topics

UsernamePublicRestriction

Register

PS085407

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel